J&J Continues To Settle Morcellator Cancer Lawsuits Reports Southern Med Law


Southern Med Law Represents Women In Morcellator Cancer Lawsuits Alleging Power Morcellation Spread Undetected Uterine Cancer, Including Leiomyosarcoma

Power-Morcellator-Lawsuit-Uterine-CancerSouthern Med Law has settled morcellator cancer lawsuits against Johnson & Johnson’s subsidiary, Ethicon Inc., which makes laparoscopic power morcellators, but continues to litigate morcellator lawsuits against Storz. Dr. François Blaudeau, co-founder of Southern Med Law was a member of the Plaintiffs’ Steering Committee until settling the firms uterine cancer lawsuits against Ethicon pending in the U.S. District Court, District of Kansas.

The attorney’s at Southern Med Law were the first to file morcellator cancer lawsuits nationally and the first to resolve and settle lawsuits filed on behalf of women who underwent laproscopic morcellation and were later diagnosed with Leiomyosarcoma or uterine cancer. “We’ve got people that are dying,” Dr. Blaudeau told the Wall Street Journal. One Southern Med Law power morcellator lawsuit involved a Michigan woman who was diagnosed with sarcoma after undergoing a hysterectomy. The firm urges women or their families that have been diagnosed with uterine cancer following a hysterectomy using laproscopic power morcellation to contact one of the firms attorneys by calling 1-205-547-5525 or visiting www.southernmedlaw.com for more information and to submit a contact form. (Power Morcellator Lawsuit Case No. 3:15-cv-03976, U.S. District Court, District of South Carolina)

Of an estimated 100 morcellator cancer lawsuits pending, Johnson & Johnson has settled about 70 cases over the past few months. While the amounts have not been disclosed, uterine cancer lawsuits settlements have ranged from $100,000 to $1 million and vary according to the woman’s age, health condition, and whether she had children, according to a Wall Street Journal report.
[wsj.com/articles/johnson-johnson-settling-cases-tied-to-device-that-spread-uterine-cancer-1458324981, Wall Street Journal, March 18, 2016]

Dr. Blaudeau and Southern Med Law have been fighting for the rights of morcellator cancer victims. Prior to his appointment to the Plaintiffs’ Steering Committee. Dr. Blaudeau served as lead counsel in what was the first power morcellator cancer lawsuit filed in a U.S. federal court. The lawsuit was filed on behalf of a Pennsylvania man whose 53-year-old wife died from leiomyosarcoma after undergoing a robot-assisted hysterectomy in March 2012. The lawsuit against morcellator manufacturers, LiNA Medical APS, Kebomed AB & LiNA Medical US, were settled for an undisclosed amount in July. (Case No. 5:14-cv-1557, U.S. District Court, Eastern District of Pennsylvania)

How Do Laparoscopic Power Morcellators Spread Uterine Cancer

Laparoscopic power morcellators are used during a hysterectomy (removal of uterus) or a myomectomy (removal of fibroids). The morcellator cuts up fibroids into fragments that are removed through small incisions in the abdomen. Undetected cancer cells are hidden in the uterine fragments being removed. The cancer cells are spread into the abdominal and pelvic cavity and disseminated throughout the body, according to morcellator cancer complaints. The U.S. Food and Drug Administration (FDA) estimates the prevalence of unsuspected uterine sarcoma in women undergoing a hysterectomy or myomectomy to remove benign fibroids is 1 in 352 and the prevalence of unsuspected uterine leiomyosarcoma is 1 in 498.
[fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm424443.htm, November 24, 2014]

Johnson & Johnson voluntarily stopped the global sales of Ethicon’s power morcellators after the FDA warned in April 2014 that the surgical devices can spread cancer in the abdominal area and throughout the body. Six months later, the federal agency ordered a black box warning on power morcellators and warned against using the device in the majority of women undergoing hysterectomy or myomectomy for uterine fibroids. The FBI is investigating whether Johnson & Johnson knew, and when did it know, about the cancer risks linked to its surgical devices. Additionally, a 12-member Congressional group has called for an investigation of power morcellators and what they consider the FDA’s slow response to complaints about the surgical device.
[wsj.com/articles/johnson-johnson-to-call-for-voluntary-return-of-morcellators-1406754350, Wall Street Journal]
[wsj.com/articles/fbi-is-investigating-surgical-device-1432746641, Wall Street Journal]

About Southern Med Law and Filing A Power Morcellator Lawsuit:

Southern Med Law is an experienced law firm providing legal representation to the men and women across the country who have been victims of negligent personal injuries, medical malpractice, dangerous drugs, faulty medical devices and defective products. Led by Dr. François Blaudeau, an attorney and a practicing obstetrician/gynecologist, the legal staff at Southern Med Law possesses a deep understanding of the complex medical and legal questions at issue in all manner of product liability and personal injury claims. They’re not afraid to take on the nation’s largest corporations in their pursuit of justice, and are committed to ensuring that all victims have access to the type of aggressive legal advocacy that assures success.

Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203
Phone: 205-547-5525

Fax: 205-547-5526


This entry was posted in Southern Med Law | Article. Bookmark the permalink.